The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
The genetic background of Parkinson's disease: current progress and future prospects
Open accessAbstract
Almost two decades of genetic research in Parkinson's disease (PD) have remarkably increased our knowledge regarding the genetic basis of PD with numerous genes and genetic loci having been found to cause familial PD or affect the risk for PD. Approximately 5-10% of PD patients have monogenic forms of the disease, exhibiting a classical Mendelian type of inheritance, however, the majority PD cases are sporadic, probably caused by a combination of genetic and environmental risk factors. Nowadays, six genes, alpha synuclein, LRRK2, VPS35, Parkin, PINK1 and DJ-1, have definitely been associated with an autosomal dominant or recessive PD mode of inheritance. The advent of genome-wide association studies (GWAS) and the implementation of new technologies, like next generation sequencing (NGS) and exome sequencing has undoubtedly greatly aided the identification on novel risk variants for sporadic PD. In this review, we will summarize the current progress and future prospects in the field of PD genetics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán-Ruı́z, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munain, A. L., Aparicio, S., Gil, A. M., Khan, N., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,405
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135
α-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024 · cited 2×
“The loss-of-function effect of Parkin mutations result in inactivation of its E3 ligase function, failure of ubiquitination of the targeted proteins and therefore a toxic build-up of proteins that are no longer effectively degraded by the parkindependent ubiqutin/proteosome pathway (61).”
BackgroundInternational Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705
The ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
Ubiquitin is phosphorylated by PINK1 to activate parkin
Koyano, F., Okatsu, K., Kosako, H., Tamura, Y., Go, E., Kimura, M., Kimura, Y., Tsuchiya, H., Yoshihara, H., Hirokawa, T., et al. (2014) · Nature · doi:10.1038/nature13392 · Cited by 1,477
Healy, D. G., Falchi, M., O'Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C. P., Goldwurm, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70117-0 · Cited by 1,425
Mazzulli, J. R., Xu, Y.-H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., Sidransky, E., Grabowski, G. A., & Krainc, D. (2011) · Cell · doi:10.1016/j.cell.2011.06.001 · Cited by 1,341
Genetic diagnosis by whole exome capture and massively parallel DNA sequencing
Choi, M., Scholl, U. I., Ji, W., Liu, T., Tikhonova, I. R., Zumbo, P., Nayir, A., Bakkaloğlu, A., Özen, S., Sanjad, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910672106 · Cited by 1,329
Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Kawaguchi, T., Tsunoda, T., Watanabe, M., Takeda, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.485 · Cited by 1,324
Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1884 · Cited by 1,208
Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401135200 · Cited by 995
Parkinson's disease: from monogenic forms to genetic susceptibility factors
Lesage, S., & Brice, A. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp012 · Cited by 945
The diagnosis of Parkinson’s disease
Tolosa, E., Wenning, G., & Poewe, W. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70285-4 · Cited by 902
A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease
Zimprich, A., Benet-Pagès, A., Struhal, W., Graf, E., Eck, S. H., Offman, M. N., Haubenberger, D., Spielberger, S., Schulte, E. C., Lichtner, P., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.008 · Cited by 816
VPS35 mutations in Parkinson disease
Vilariño-Güell, C., Wider, C., Ross, O. A., Dachsel, J. C., Kachergus, J. M., Lincoln, S. J., Soto-Ortolaza, A. I., Cobb, S. A., Wilhoite, G. J., Bacon, J. A., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.001 · Cited by 800
Mapping of a gene for Parkinson's disease to chromosome 4q21-q23
Polymeropoulos, M. H., Higgins, J. J., Golbe, L. I., Johnson, W. G., Ide, S. E., Di Iorio, G., Sanges, G., Stenroos, E. S., Pho, L. T., Schaffer, A. A., et al. (1996) · Science · doi:10.1126/science.274.5290.1197 · Cited by 788 · cited 1×
“In 1996, by linkage mapping, the gene was located to the long arm of chromosome 4q21 (11) and a year later the finding of a chromosomal region linked to PD was confirmed by the identification of the missense mutation A53T in alpha synuclein in Italian and Greek families with autosomal dominant PD (6).”
BackgroundA common LRRK2 mutation in idiopathic Parkinson's disease
Gilks, W. P., Abou-Sleiman, P. M., Gandhi, S., Jain, S., Singleton, A., Lees, A. J., Shaw, K., Bhatia, K. P., Bonifati, V., Quinn, N. P., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17830-1 · Cited by 774
G51D α‐synuclein mutation causes a novel Parkinsonian–pyramidal syndrome
Lesage, S., Anheim, M., Letournel, F., Bousset, L., Honoré, A., Rozas, N., Pieri, L., Madiona, K., Dürr, A., Melki, R., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23894 · Cited by 711
Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
Appel‐Cresswell, S., Vilarino‐Guell, C., Encarnacion, M., Sherman, H., Yu, I., Shah, B., Weir, D., Thompson, C., Szu‐Tu, C., Trinh, J., et al. (2013) · Movement Disorders · doi:10.1002/mds.25421 · Cited by 667
LRRK2 G2019S as a Cause of Parkinson's Disease in Ashkenazi Jews
Ozelius, L. J., Senthil, G., Saunders-Pullman, R., Ohmann, E., Deligtisch, A., Tagliati, M., Hunt, A. L., Klein, C., Henick, B., Hailpern, S. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmc055509 · Cited by 665
(2004) · doi:10.1002/ana.10846 · Cited by 614
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
Corti, O., Lesage, S., & Brice, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00022.2010 · Cited by 611
Interplay of LRRK2 with chaperone-mediated autophagy
Orenstein, S. J., Kuo, S.-H., Tasset, I., Arias, E., Koga, H., Fernandez-Carasa, I., Cortes, E., Honig, L. S., Dauer, W., Consiglio, A., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3350 · Cited by 588
Cordell, H. J., & Clayton, D. G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67424-7 · Cited by 582
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease
Strauss, K. M., Martins, L. M., Plun-Favreau, H., Marx, F. P., Kautzmann, S., Berg, D., Gasser, T., Wszolek, Z., Müller, T., Bornemann, A., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi215 · Cited by 568
LIMP-2 Is a Receptor for Lysosomal Mannose-6-Phosphate-Independent Targeting of β-Glucocerebrosidase
Reczek, D., Schwake, M., Schröder, J., Hughes, H., Blanz, J., Jin, X., Brondyk, W., Van Patten, S., Edmunds, T., & Saftig, P. (2007) · Cell · doi:10.1016/j.cell.2007.10.018 · Cited by 542
Kachergus, J., Mata, I. F., Hulihan, M., Taylor, J. P., Lincoln, S., Aasly, J., Gibson, J. M., Ross, O. A., Lynch, T., Wiley, J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429256 · Cited by 541
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease
Di Fonzo, A., Rohé, C. F., Ferreira, J., Chien, H. F., Vacca, L., Stocchi, F., Guedes, L., Fabrizio, E., Manfredi, M., Vanacore, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17829-5 · Cited by 531
Abbas, N., Lucking, C. B., Ricard, S., Durr, A., Bonifati, V., De Michele, G., Bouley, S., Vaughan, J. R., Gasser, T., Marconi, R., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.567 · Cited by 530
Lill, C. M., Roehr, J. T., McQueen, M. B., Kavvoura, F. K., Bagade, S., Schjeide, B.-M. M., Schjeide, L. M., Meissner, E., Zauft, U., Allen, N. C., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002548 · Cited by 529
RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson’s Disease Risk
MacLeod, D. A., Rhinn, H., Kuwahara, T., Zolin, A., Di Paolo, G., McCabe, B. D., Marder, K. S., Honig, L. S., Clark, L. N., Small, S. A., et al. (2013) · Neuron · doi:10.1016/j.neuron.2012.11.033 · Cited by 516
LRRK2 G2019S as a Cause of Parkinson's Disease in North African Arabs
Lesage, S., Dürr, A., Tazir, M., Lohmann, E., Leutenegger, A.-L., Janin, S., Pollak, P., & Brice, A. (2006) · New England Journal of Medicine · doi:10.1056/nejmc055540 · Cited by 494
EFNS/MDS‐ES recommendations for the diagnosis of Parkinson's disease
Berardelli, A., Wenning, G. K., Antonini, A., Berg, D., Bloem, B. R., Bonifati, V., Brooks, D., Burn, D. J., Colosimo, C., Fanciulli, A., et al. (2013) · European Journal of Neurology · doi:10.1111/ene.12022 · Cited by 489
Lewy bodies and parkinsonism in families with parkin mutations
Farrer, M., Chan, P., Chen, R., Tan, L., Lincoln, S., Hernandez, D., Forno, L., Gwinn‐Hardy, K., Petrucelli, L., Hussey, J., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1132 · Cited by 485
Characterization of PLA2G6 as a locus for dystonia‐parkinsonism
Paisan‐Ruiz, C., Bhatia, K. P., Li, A., Hernandez, D., Davis, M., Wood, N. W., Hardy, J., Houlden, H., Singleton, A., & Schneider, S. A. (2009) · Annals of Neurology · doi:10.1002/ana.21415 · Cited by 480
Edwards, T. L., Scott, W. K., Almonte, C., Burt, A., Powell, E. H., Beecham, G. W., Wang, L., Züchner, S., Konidari, I., Wang, G., et al. (2010) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2009.00560.x · Cited by 465
A susceptibility locus for Parkinson's disease maps to chromosome 2p13
Gasser, T., Müller-Myhsok, B., Wszolek, Z. K., Oehlmann, R., Calne, D. B., Bonifati, V., Bereznai, B., Fabrizio, E., Vieregge, P., & Horstmann, R. D. (1998) · Nature Genetics · doi:10.1038/ng0398-262 · Cited by 458
Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease
Nichols, W. C., Pankratz, N., Hernandez, D., Paisán-Ruíz, C., Jain, S., Halter, C. A., Michaels, V. E., Reed, T., Rudolph, A., Shults, C. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17828-3 · Cited by 457
Kiely, A. P., Asi, Y. T., Kara, E., Limousin, P., Ling, H., Lewis, P., Proukakis, C., Quinn, N., Lees, A. J., Hardy, J., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1096-7 · Cited by 451
A novel α-synuclein missense mutation in Parkinson disease
Proukakis, C., Dudzik, C. G., Brier, T., MacKay, D. S., Cooper, J. M., Millhauser, G. L., Houlden, H., & Schapira, A. H. (2013) · Neurology · doi:10.1212/wnl.0b013e31828727ba · Cited by 449
DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism
Bonifati, V., Rizzu, P., Squitieri, F., Krieger, E., Vanacore, N., van Swieten, J. C., Brice, A., van Duijn, C. M., Oostra, B., Meco, G., et al. (2003) · Neurological Sciences · doi:10.1007/s10072-003-0108-0 · Cited by 427
Occurrence of Parkinson's syndrome in type 1 Gaucher disease
Neudorfer, O., Giladi, N., Elstein, D., Abrahamov, A., Turezkite, T., Aghai, E., Reches, A., Bembi, B., & Zimran, A. (1996) · QJM · doi:10.1093/qjmed/89.9.691 · Cited by 401
Parkinsonism among Gaucher disease carriers
Goker-Alpan, O., Schiffmann, R., LaMarca, M. E., Nussbaum, R. L., McInerney-Leo, A., & Sidransky, E. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.024455 · Cited by 366
FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome
Fonzo, A. D., Dekker, M. C. J., Montagna, P., Baruzzi, A., Yonova, E. H., Guedes, L. C., Szczerbinska, A., Zhao, T., Dubbel-Hulsman, L. O. M., Wouters, C. H., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000338144.10967.2b · Cited by 364
The Parkinson's disease–linked proteins Fbxo7 and Parkin interact to mediate mitophagy
Burchell, V. S., Nelson, D. E., Sanchez-Martinez, A., Delgado-Camprubi, M., Ivatt, R. M., Pogson, J. H., Randle, S. J., Wray, S., Lewis, P. A., Houlden, H., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3489 · Cited by 341
Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes
Bonifati, V., Rohé, C. F., Breedveld, G. J., Fabrizio, E., De Mari, M., Tassorelli, C., Tavella, A., Marconi, R., Nicholl, D. J., Chien, H. F., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000167546.39375.82 · Cited by 338
Krebs, C. E., Karkheiran, S., Powell, J. C., Cao, M., Makarov, V., Darvish, H., Di Paolo, G., Walker, R. H., Shahidi, G. A., Buxbaum, J. D., et al. (2013) · Human Mutation · doi:10.1002/humu.22372 · Cited by 336
Mutation in the SYNJ1 Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism
Quadri, M., Fang, M., Picillo, M., Olgiati, S., Breedveld, G. J., Graafland, J., Wu, B., Xu, F., Erro, R., Amboni, M., et al. (2013) · Human Mutation · doi:10.1002/humu.22373 · Cited by 320
Edvardson, S., Cinnamon, Y., Ta-Shma, A., Shaag, A., Yim, Y.-I., Zenvirt, S., Jalas, C., Lesage, S., Brice, A., Taraboulos, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036458 · Cited by 318
DNAJC13 mutations in Parkinson disease
Vilariño-Güell, C., Rajput, A., Milnerwood, A. J., Shah, B., Szu-Tu, C., Trinh, J., Yu, I., Encarnacion, M., Munsie, L. N., Tapia, L., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt570 · Cited by 313
Cullen, V., Sardi, S. P., Ng, J., Xu, Y., Sun, Y., Tomlinson, J. J., Kolodziej, P., Kahn, I., Saftig, P., Woulfe, J., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22400 · Cited by 303
Translation Initiator EIF4G1 Mutations in Familial Parkinson Disease
Chartier-Harlin, M.-C., Dachsel, J. C., Vilariño-Güell, C., Lincoln, S. J., Leprêtre, F., Hulihan, M. M., Kachergus, J., Milnerwood, A. J., Tapia, L., Song, M.-S., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.08.009 · Cited by 299
Deficiency of ATP13A2 Leads to Lysosomal Dysfunction, α-Synuclein Accumulation, and Neurotoxicity
Usenovic, M., Tresse, E., Mazzulli, J. R., Taylor, J. P., & Krainc, D. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5575-11.2012 · Cited by 291
Dawn Teare, M., & Barrett, J. H. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67382-5 · Cited by 271
Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*
Berg, D., Schweitzer, K. J., Leitner, P., Zimprich, A., Lichtner, P., Belcredi, P., Brüssel, T., Schulte, C., Maass, S., Nägele, T., et al. (2005) · Brain · doi:10.1093/brain/awh666 · Cited by 261
Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease
Gan-Or, Z., Dion, P. A., & Rouleau, G. A. (2015) · Autophagy · doi:10.1080/15548627.2015.1067364 · Cited by 260
A susceptibility gene for late‐onset idiopathic Parkinson's disease
Hicks, A. A., Pétursson, H., Jónsson, T., Stefánsson, H., Jóhannsdóttir, H. S., Sainz, J., Frigge, M. L., Kong, A., Gulcher, J. R., Stefánsson, K., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10324 · Cited by 260
PINK1-linked parkinsonism is associated with Lewy body pathology
Samaranch, L., Lorenzo-Betancor, O., Arbelo, J. M., Ferrer, I., Lorenzo, E., Irigoyen, J., Pastor, M. A., Marrero, C., Isla, C., Herrera-Henriquez, J., et al. (2010) · Brain · doi:10.1093/brain/awq051 · Cited by 258
Chiba-Falek, O. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.26.3101 · Cited by 242
Distribution, type, and origin of Parkin mutations: Review and case studies
Hedrich, K., Eskelson, C., Wilmot, B., Marder, K., Harris, J., Garrels, J., Meija‐Santana, H., Vieregge, P., Jacobs, H., Bressman, S. B., et al. (2004) · Movement Disorders · doi:10.1002/mds.20234 · Cited by 225
A Ubl/ubiquitin switch in the activation of Parkin
Sauvé, V., Lilov, A., Seirafi, M., Vranas, M., Rasool, S., Kozlov, G., Sprules, T., Wang, J., Trempe, J., & Gehring, K. (2015) · The EMBO Journal · doi:10.15252/embj.201592237 · Cited by 212
Mizuta, I., Satake, W., Nakabayashi, Y., Ito, C., Suzuki, S., Momose, Y., Nagai, Y., Oka, A., Inoko, H., Fukae, J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl030 · Cited by 207
Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia
Farrer, M. J., Stone, J. T., Lin, C.-H., Dächsel, J. C., Hulihan, M. M., Haugarvoll, K., Ross, O. A., & Wu, R.-M. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.12.001 · Cited by 205
Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease
Ross, O. A., Wu, Y., Lee, M., Funayama, M., Chen, M., Soto, A. I., Mata, I. F., Lee‐Chen, G., Chen, C. M., Tang, M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21405 · Cited by 196
Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa
Ibáñez, P., Lesage, S., Lohmann, E., Thobois, S., Michele, G. D., Borg, M., Agid, Y., Dürr, A., & Brice, A. (2006) · Brain · doi:10.1093/brain/awl005 · Cited by 182
SNCA Variant Associated With Parkinson Disease and Plasma α-Synuclein Level
Mata, I. F., Shi, M., Agarwal, P., Chung, K. A., Edwards, K. L., Factor, S. A., Galasko, D. R., Ginghina, C., Griffith, A., Higgins, D. S., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.279 · Cited by 177
Manning-Boğ, A. B., Schüle, B., & Langston, J. W. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.06.009 · Cited by 176
Genetic basis of Parkinson's disease: inheritance, penetrance, and expression
Gasser, T. (2011) · The Application of Clinical Genetics · doi:10.2147/tacg.s11639 · Cited by 172
Gasser, T., Hardy, J., & Mizuno, Y. (2011) · Movement Disorders · doi:10.1002/mds.23637 · Cited by 166
C9orf72 repeat expansions are a rare genetic cause of parkinsonism
Lesage, S., Le Ber, I., Condroyer, C., Broussolle, E., Gabelle, A., Thobois, S., Pasquier, F., Mondon, K., Dion, P. A., Rochefort, D., et al. (2013) · Brain · doi:10.1093/brain/aws357 · Cited by 164
Significant Linkage of Parkinson Disease to Chromosome 2q36-37
Pankratz, N., Nichols, W. C., Uniacke, S. K., Halter, C., Rudolph, A., Shults, C., Conneally, P. M., & Foroud, T. (2003) · The American Journal of Human Genetics · doi:10.1086/374383 · Cited by 161
Tau haplotypes regulate transcription and are associated with Parkinson's disease
Kwok, J. B. J., Teber, E. T., Loy, C., Hallupp, M., Nicholson, G., Mellick, G. D., Buchanan, D. D., Silburn, P. A., & Schofield, P. R. (2004) · Annals of Neurology · doi:10.1002/ana.10826 · Cited by 159
The many faces of alpha‐synuclein mutations
Kasten, M., & Klein, C. (2013) · Movement Disorders · doi:10.1002/mds.25499 · Cited by 157
Ibáñez, P., Lesage, S., Janin, S., Lohmann, E., Durif, F., Destée, A., Bonnet, A.-M., Brefel‐Courbon, C., Heath, S., Zélénika, D., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.555 · Cited by 155
Pankratz, N., Nichols, W. C., Uniacke, S. K., Halter, C., Murrell, J., Rudolph, A., Shults, C. W., Conneally, P. M., & Foroud, T. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg270 · Cited by 151
Increased incidence of Parkinson disease among relatives of patients with Gaucher disease
Halperin, A., Elstein, D., & Zimran, A. (2006) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2006.02.004 · Cited by 138
Lesage, S., Leutenegger, A., Ibáñez, P., Janin, S., Lohmann, E., Dürr, A., & Brice, A. (2005) · The American Journal of Human Genetics · doi:10.1086/432422 · Cited by 135
Mutated α-synuclein gene in two Greek kindreds with familial PD: Incomplete penetrance?
Papadimitriou, A., Veletza, V., Hadjigeorgiou, G. M., Patrikiou, A., Hirano, M., & Anastasopoulos, I. (1999) · Neurology · doi:10.1212/wnl.52.3.651 · Cited by 132
Ivatt, R. M., Sanchez-Martinez, A., Godena, V. K., Brown, S., Ziviani, E., & Whitworth, A. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321207111 · Cited by 130
Athanassiadou, A., Voutsinas, G. E., Psiouri, L., Leroy, E., Polymeropoulos, M. H., Ilias, A., Maniatis, G. M., & Papapetropoulos, T. (1999) · The American Journal of Human Genetics · doi:10.1086/302486 · Cited by 126
LRRK2 in Parkinson’s disease: genetic and clinical studies from patients
Kumari, U., & Tan, E. K. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07344.x · Cited by 125
Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal
Brás, J., Paisán‐Ruiz, C., Guerreiro, R. J., Ribeiro, M. H., Morgadinho, A., Januário, C., Sidransky, E., Oliveira, C. R., & Singleton, A. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.016 · Cited by 117
Glucocerebrosidase mutations and the pathogenesis of Parkinson disease
Beavan, M. S., & Schapira, A. H. V. (2013) · Annals of Medicine · doi:10.3109/07853890.2013.849003 · Cited by 115
Cronin, K. D., Ge, D., Manninger, P., Linnertz, C. L., Rossoshek, A., Orrison, B. M., Bernard, D. J., El‐Agnaf, O. M. A., Schlossmacher, M. G., Nussbaum, R. L., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp265 · Cited by 112
Pathogenic Mechanisms of Neurodegeneration in Parkinson Disease
Mullin, S., & Schapira, A. H. V. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2014.09.010 · Cited by 108
The Role and Challenges of Exome Sequencing in Studies of Human Diseases
Wang, Z., Liu, X., Yang, B., & Gelernter, J. E. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00160 · Cited by 104
The VPS35 gene and Parkinson's disease
Deng, H., Gao, K., & Jankovic, J. J. (2013) · Movement Disorders · doi:10.1002/mds.25430 · Cited by 98
LRRK2 R1441G in Spanish patients with Parkinson's disease
Mata, I. F., Taylor, J. P., Kachergus, J. M., Hulihan, M., Huerta, C., Lahoz, C., Estrada, M. B., Guisasola, L. M., Salvador, C., Ribacoba, R., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.033 · Cited by 98
Chiba‐Falek, O., Kowalak, J. A., Smulson, M. E., & Nussbaum, R. L. (2005) · The American Journal of Human Genetics · doi:10.1086/428655 · Cited by 97
Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece
Kalinderi, K., Bostantjopoulou, S., Paisán‐Ruiz, C., Katsarou, Z., Hardy, J., & Fidani, L. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.01.029 · Cited by 94
Self-citationFrequency of the D620N Mutation in VPS35 in Parkinson Disease
Kumar, K. R., Weißbach, A., Heldmann, M., Kasten, M., Tunç, S., Sue, C. M., Svetel, M. V., Kostić, V., Segura‐Aguilar, J., Ramı́rez, A., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.3367 · Cited by 94
Clinical features of parkinsonian patients with the α‐synuclein (G209A) mutation
Bostantjopoulou, S., Katsarou, Z., Papadimitriou, A., Veletza, V., Hatzigeorgiou, G., & Lees, A. J. (2001) · Movement Disorders · doi:10.1002/mds.1221 · Cited by 85
Self-citationGorostidi, A., Ruiz‐Martínez, J., de Munaín, A. L., Alzualde, A., & Martí-Massó, J. F. (2008) · Neurogenetics · doi:10.1007/s10048-008-0162-0 · Cited by 81
Fitzgerald, J. C., & Plun‐Favreau, H. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06708.x · Cited by 68
Parkinsonism syndrome in heterozygotes for Niemann–Pick C1
Kluenemann, H., Nutt, J. G., Davis, M. Y., & Bird, T. D. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.08.033 · Cited by 67
Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease
Vandrovcová, J., Pittman, A. M., Malzer, E., Abou‐Sleiman, P. M., Lees, A. J., Wood, N. W., & de Silva, R. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.019 · Cited by 67
Four Copies of SNCA Responsible for Autosomal Dominant Parkinson’s Disease in Two Italian Siblings
Ferese, R., Modugno, N., Campopiano, R., Santilli, M., Zampatti, S., Giardina, E., Nardone, A., Postorivo, D., Fornai, F., Novelli, G., et al. (2015) · Parkinson s Disease · doi:10.1155/2015/546462 · Cited by 66
Lesage, S., Patin, É., Condroyer, C., Leutenegger, A., Lohmann, E., Giladi, N., Bar‐Shira, A., Belarbi, S., Hecham, N., Pollak, P., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq081 · Cited by 63
Pharmacological treatment and the prospect of pharmacogenetics in Parkinson’s disease
Kalinderi, K., Fidani, L., Katsarou, Z., & Bostantjopoulou, S. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02793.x · Cited by 61
Self-citationGenome-wide association studies in neurological disorders
Simón‐Sánchez, J., & Singleton, A. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70241-2 · Cited by 59
Genetic causes of Parkinson's disease and their links to autophagy regulation
Pan, P., & Yue, Z. (2013) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(13)70037-3 · Cited by 54
Association of GWAS loci with PD in China
Chang, X., Mao, X., Li, H., et al. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31167 · Cited by 54
Glucocerebrosidase mutations in a S erbian P arkinson's disease population
Kumar, K. R., Ramı́rez, A., Göbel, A., Kresojević, N. D., Svetel, M. V., Lohmann, K., Sue, C. M., Rolfs, A., Mazzulli, J. R., Alcalay, R. N., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03817.x · Cited by 54
TheEIF4G1gene and Parkinson's disease
Deng, H., Wu, Y. Q., & Jankovic, J. J. (2015) · Acta Neurologica Scandinavica · doi:10.1111/ane.12397 · Cited by 51
LAMP2A as a therapeutic target in Parkinson disease
Xilouri, M., Brekk, O. R., Kirik, D., & Stefanis, L. (2013) · Autophagy · doi:10.4161/auto.26451 · Cited by 49
DJ1 represses glycolysis and cell proliferation by transcriptionally up-regulatingpink1
Requejo-Aguilar, R., López-Fabuel, I., Jiménez-Blasco, D., Fernández, E., Almeida, Á., & Bolaños, J. P. (2015) · Biochemical Journal · doi:10.1042/bj20141025 · Cited by 49
George, A. A., Hayden, S., Holzhausen, L. C., Ma, E. Y., Suzuki, S. C., & Brockerhoff, S. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084394 · Cited by 48
Tokutake, T., Ishikawa, A., Yoshimura, N., et al. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.11.008 · Cited by 45
The Tau Gene Haplotype H1 Confers a Susceptibility to Parkinson’s Disease
Zhang, J., Song, Y., Chen, H., & Fan, D. (2004) · European Neurology · doi:10.1159/000082956 · Cited by 43
The significance of GBA for Parkinson's disease
Brockmann, K., & Berg, D. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9714-7 · Cited by 41
Mitochondrial DNA sequence associations with dementia and amyloid-β in elderly African Americans
Tranah, G. J., Yokoyama, J. S., Katzman, S. M., Nalls, M. A., Newman, A. B., Harris, T. B., Cesari, M., Manini, T. M., Schork, N. J., Cummings, S. R., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.023 · Cited by 40
Evaluation of non-motor symptoms in Parkinson's Disease: An underestimated necessity.
Bostantjopoulou, S., Katsarou, Z., Karakasis, C., Peitsidou, E., Milioni, D., & Rossopoulos, N. (2013) · Europe PMC (PubMed Central) · Cited by 37
Self-citationUsefulness of Genetic Testing in PD and PD Trials: A Balanced Review
Gasser, T. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-140507 · Cited by 36
Seaman, M. N. J., & Freeman, C. (2014) · Communicative & Integrative Biology · doi:10.4161/cib.29483 · Cited by 34
Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease
Hatano, T., Funayama, M., Kubo, S.-I., Mata, I. F., Oji, Y., Mori, A., Zabetian, C. P., Waldherr, S. M., Yoshino, H., Oyama, G., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.025 · Cited by 33
Genomics and Bioinformatics of Parkinson's DiseasePreprint
Scholz, S. W., Mhyre, T. R., Ressom, H. W., Shah, S. A., & Federoff, H. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009449 · Cited by 32
Association Studies of Sporadic Parkinson’s Disease in the Genomic Era
Labbé, C., & Ross, O. A. (2014) · Current Genomics · doi:10.2174/1389202914666131210212745 · Cited by 30
Candidate genes for Parkinson disease: Lessons from pathogenesis
Rosa, P. D., Marini, E. S., Gelmetti, V., & Valente, E. M. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.04.042 · Cited by 29
Olfactory dysfunction in sporadic Parkinson's Disease and LRRK2 carriers
Johansen, K. K., Warø, B., & Aasly, J. O. (2013) · Acta Neurologica Scandinavica · doi:10.1111/ane.12172 · Cited by 28
Association of the Tau haplotype with Parkinson's disease in the Greek population
Fidani, L., Kalinderi, K., Bostantjopoulou, S., Clarimón, J., Goulas, A., Katsarou, Z., Hardy, J., & Kotsis, A. (2006) · Movement Disorders · doi:10.1002/mds.20864 · Cited by 26
Self-citationThe Use of Next-Generation Sequencing in Movement Disorders
Krebs, C. E., & Paisán‐Ruiz, C. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00075 · Cited by 24
Clusterin variants are not associated with southern Chinese patients with Alzheimer's disease
Lu, S.-J., Li, H., Sun, Y., Liu, Z., Yang, P., & Wu, Z. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.015 · Cited by 22
Is the G2019S LRRK2 mutation common in all southern European populations?
Papapetropoulos, S., Adi, N., Shehadeh, L. A., et al. (2008) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2007.08.013 · Cited by 21
The LRRK2 gene in Parkinson's disease: mutation screening in patients from Germany
Schlitter, A. M. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.083022 · Cited by 20
Assessment of Parkinson's disease risk loci in Greece
Kara, E., Xiromerisiou, G., Spanaki, C., Bozi, M., Koutsis, G., Πάνας, Μ., Dardiotis, E., Ralli, S., Brás, J., Letson, C., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.07.011 · Cited by 19
Self-citationFrom 1997 to 2007: A decade journey through the H1 haplotype on 17q21 chromosome
Kalinderi, K., Fidani, L., & Bostantjopoulou, S. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.03.001 · Cited by 19
Self-citationGenetic screening for LRRK2 gene G2019S mutation in Parkinson's disease patients from Southern Italy
Rosa, A. D., Criscuolo, C., Mancini, P., Martino, M. D., Giordano, I., Pappatà, S., Filla, A., & Michele, G. D. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.05.011 · Cited by 18
MTHFRC677T variant reduces risk of sporadic Parkinson's disease in ethnic Chinese
Liao, Q., Li, N. N., Mao, X.-Y., Chang, X. L., Da⁃chun, Z. H. A. O., Zhang, J. H., Yu, W.-J., Tan, E., & Peng, R. (2014) · Acta Neurologica Scandinavica · doi:10.1111/ane.12245 · Cited by 11
Kalinderi, K., Bostantjopoulou, S., Katsarou, Z., Dimikiotou, M., & Fidani, L. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.08.020 · Cited by 10
Self-citationSMPD1 mutations and Parkinson disease
Dagan, E., Adir, V., Schlesinger, I., Borochowitz, Z. U., Ayoub, M., Mory, A., Nassar, M., Kurolap, A., Aharon‐Peretz, J., & Gershoni‐Baruch, R. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.08.019 · Cited by 10
Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease
GEO-PD Consortium (2014) · VUBIR (Vrije Universiteit Brussel) · doi:10.1212/wnl.0000000000001012
Cited by
Colacurcio, D. J., & Nixon, R. A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.004 · Cited by 548
The genetics of Parkinson disease
Deng, H., Wang, P., & Jankovic, J. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.12.007 · Cited by 530
Parkinson's Disease and the Environment
Ball, N., Teo, W.-P., Chandra, S., & Chapman, J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00218 · Cited by 480
Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions
Dong-Chen, X., Yong, C., Yang, X., Chen-Yu, S., & Li-Hua, P. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01353-3 · Cited by 469
Patricio, F., Morales-Andrade, A. A., Patricio-Martínez, A., & Limón, I. D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.595635 · Cited by 129
Metadata
- Authors
- Kalinderi, K., Bostantjopoulou, S., & Fidani, L.
- Venue
- Acta Neurologica Scandinavica
- Publisher
- Hindawi Limited
- Published
- 2016-02-12
- Volume
- 134
- Issue
- 5
- Pages
- 314-326
- ISSN
- 0001-6314 (ISSN-L)
- OpenAlex
- W2259808367
- Cited by
- 273
- References
- 142
- FWCI
- 23.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.